结直肠癌,ADAM15,p-EGFR,迁移,侵袭," /> 结直肠癌,ADAM15,p-EGFR,迁移,侵袭,"/> Colorectal cancer,ADAM15,p-EGFR,Migration,Invasion ,"/>  <span style="font-family:宋体;">ADAM15</span><span style="font-family:宋体;">通过激活<span>EGFR</span>促进结直肠癌细胞的转移侵袭<span></span></span>

临床肿瘤学杂志 ›› 2018, Vol. 23 ›› Issue (10): 881-885.

• 论著 • 上一篇    下一篇

 ADAM15通过激活EGFR促进结直肠癌细胞的转移侵袭

  

  1.  

    473009  河南南阳  南阳市中心医院普外科

  • 收稿日期:2018-04-22 修回日期:2018-08-16 出版日期:2018-10-31 发布日期:2019-03-20
  • 通讯作者: 宋展 E-mail:E-mail:13079426@qq.com

 ADAM15 promotes metastasis and invasion of colorectal cancer cells by activating EGFR

  1. Department of General Surgery Nanyang Central Hospital Nanyang 473009
  • Received:2018-04-22 Revised:2018-08-16 Online:2018-10-31 Published:2019-03-20
  • Contact: SONG Zhan E-mail:E-mail:13079426@qq.com

摘要:  目的  探讨结直肠癌细胞中ADAM15的表达及其对结直肠癌细胞迁移侵袭能力的影响。方法  Western blotting检测人正常结直肠黏膜细胞系FHC和人结直肠癌细胞系Caco-2SW-480DKO-1ADAM15蛋白的表达。向SW-480细胞分别转染siNCsiNC组)和siADAM15siADAM15组),细胞划痕实验和Transwell实验检测两组SW-480细胞迁移、侵袭能力;Western blotting检测siNC组、siADAM15组和FHC细胞系中p-EGFREGFRADAM15蛋白的表达。结果  Caco-2SW-480DKO-1细胞系中ADAM15表达量分别为2.01±0.1492.74±0.0532.27±0.185,均高于FHC细胞系的0.98±0.043,差异有统计学意义(P0.05)。划痕实验显示,siADAM1524 h划痕宽度与0 h划痕宽度比值为0.925±0.087,明显高于siNC组的0.326±0.031,差异有统计学意义(P0.05)。Transwell实验显示, siADAM15SW-480细胞侵袭数目为327.4±42.13,显著低于siNC组的669.7±35.21,差异有统计学意义(P0.05)。siNCSW-480细胞中p-EGFR表达量为0.89±0.097,显著高于FHC细胞系的0.42±0.035,差异有统计学意义(P0.05);siADAM15SW-480细胞中p-EGFR表达量为0.27±0.067,显著低于siNC组的0.89±0.097,差异有统计学意义(P0.05)。结论  ADAM15可能通过激活EGFR促进结直肠癌细胞的迁移侵袭过程。

关键词:  , 结直肠癌')">">结直肠癌, ADAM15, p-EGFR, 迁移, 侵袭

Abstract:  

Objective  To investigate the expression of ADAM15 in colorectal cancer cells and its effect on migration and invasion of colorectal cancer cells.

MethodsThe expression of ADAM15 protein in human normal colorectal mucosal cell line FHC and human colorectal cancer cell line Caco-2 SW-480 and DKO-1 was detected by Western blotting. SW-480 cells were transfected into siNC siNC group and siADAM15 siADAM15 group respectively. Cell scratch test and Transwell test were used to detect the migration and invasion ability of the two groups. The expressions of pEGFR EGFR and ADAM15 proteins in siNC siADAM15 and FHC were detected Western blotting. Results  The expression levels of ADAM15 in Caco-2 SW-480 and DKO-1 cell lines were 2.01±0.149 2.74 ±0.053 and 2.27 ±0.185 respectively which were higher than 0.98±0.043 in FHC cell line and the difference was statistically significant P0.05. Scratch test showed that the ratio of 24 h scratch width to 0 h scratch width in siADAM15 group was 0.925±0.087 which was significantly higher than 0.326±0.031 in siNC group and the difference was statistically significant P0.05. Transwell test showed that the invasive number of SW-480 cells in siADAM15 group was 327.4±2.13 which was significantly lower than 669.7±35.21 in siNC group P0.05. The expression of p-EGFR in SW-480 cells of siNC group was 0.89±0.097 which was significantly higher than 0.42 ±0.035 in FHC cell line and the difference was statistically significant P0.05. The expression of p-EGFR in SW-480 cells of siADAM15 group was 0.27±0.067 which was significantly lower than 0.89±0.097 of siNC group and the difference was statistically significant P0.05. Conclusion  ADAM15 may promote the migration and invasion of colorectal cancer cells by activating EGFR.

Key words:  ,

Colorectal cancer">Colorectal cancer')">">, ADAM15, p-EGFR, Migration, Invasion

中图分类号: 

  • R735.3
[1] 元建华, 李建旺, 毛山山, 崔荣花, 王美清.  Ⅰ~Ⅲ期结直肠癌中Livin的表达及其临床意义[J]. 临床肿瘤学杂志, 2018, 23(10): 910-914.
[2] 蒋文, 王礼学, 丁怀银, 郑勤, 徐瀚峰, 杨觅, 张全安.  循环肿瘤细胞监测在结直肠癌肝转移微波消融治疗中临床价值的评估[J]. 临床肿瘤学杂志, 2018, 23(10): 925-930.
[3] 何治军, 吴连宝, 韩江.  加速康复外科在结直肠癌围手术期的效果观察[J]. 临床肿瘤学杂志, 2018, 23(10): 931-936.
[4] 张德志, 张 宇, 朱少功. VEGFR2基因rs10013228多态性对R0切除结直肠癌患者预后的影响[J]. 临床肿瘤学杂志, 2018, 23(5): 424-428.
[5] 姚波, 路 娜. 放疗在同步转移直肠癌中的应用价值[J]. 临床肿瘤学杂志, 2018, 23(5): 463-466.
[6] 杨野梵, 马中华 综述, 王科明 审校. 长链非编码RNA调控结直肠癌耐药的研究进展[J]. 临床肿瘤学杂志, 2018, 23(5): 458-462.
[7] 孟存英, 安 太, 史盛梅, 张春莉, 刘 琰, 袁东红, 马 莹, 刘鹏飞. DCLK1、Bmi-1在结直肠癌中的表达及临床意义[J]. 临床肿瘤学杂志, 2018, 23(5): 419-423.
[8] 王珊珊, 汪海岩, 武 斌, 赵利红, 李 栋, 谢 彦. 甲磺酸阿帕替尼在多线治疗失败的晚期结肠癌中的近期临床疗效与安全性观察[J]. 临床肿瘤学杂志, 2018, 23(5): 453-457.
[9] 李 进,曹 君. 大肠癌单克隆抗体治疗新进展[J]. 临床肿瘤学杂志, 2009, 14(1): 1-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!